文献速递消化道肿瘤放疗放疗物理与技术

胰腺癌上腹部IMRT前是否应行功能性肾扫描?

Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer?
PubMed 文献 · Pract Radiat Oncol · 2017-06-29

该回顾性研究分析2009至2015年接受腹部放疗的204例胰腺癌患者,发现11.2%存在功能性肾扫描定义的双肾功能不对称,且血肌酐、尿素氮、GFR或肾脏大小均未能识别。作者建议当肾脏V18超过20%至30%或担忧基线肾功能时考虑功能性肾扫描。

要点

  • 204例胰腺癌患者中11.2%存在双肾功能不对称(≥60%/40%)。
  • 血BUN、Cr、GFR及肾脏大小未显著关联双肾功能不对称。
  • 肾脏V18超过20%至30%或担忧基线肾功能时建议考虑功能肾扫描。

核心结论

  • 胰腺癌患者中约11%存在功能肾扫描发现的双肾功能不对称,该不对称无法通过肾脏大小、血清BUN、Cr、GFR或显著病史识别。
  • 当肾脏辐射剂量超过V18 20%至30%或担忧基线肾功能时,应考虑行功能性肾扫描。

研究设计与样本

  • 回顾性分析2009至2015年接受腹部放疗且放疗前有功能性肾扫描的可切除、交界可切除和局部晚期胰腺癌患者204例。
  • 双肾功能不对称定义为功能肾扫描双肾差异≥60%/40%。
  • 放疗模拟定位前常规获取血清BUN、Cr、GFR及腹部CT。

主要发现

  • 204例患者中23例(11.2%)在放疗前功能肾扫描中发现双肾功能不对称。
  • Cr或BUN升高、GFR<60或提示肾功能异常的病史与双肾功能不对称无显著关联。
  • 23例双肾功能不对称患者中仅6例(26%)肾脏大小存在显著差异。

关键数值与推荐

  • 双肾功能不对称定义为功能肾扫描双肾差异≥60%/40%。
  • 肾脏V18超过20%至30%或担忧基线肾功能时考虑功能性肾扫描。

临床怎么用

  • 胰腺癌上腹部IMRT前,若肾脏V18超过20%至30%或临床担忧基线肾功能,可考虑行功能性肾扫描以评估双肾功能不对称。
  • 不应仅依靠血BUN、Cr、GFR或肾脏大小来排除双肾功能不对称。

局限性

  • 回顾性研究设计。
  • 单中心系列。
  • 功能肾扫描仅在部分患者中获取,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Upper abdominal irradiation for pancreatic cancer is administered in close proximity to the radiation-sensitive kidneys. There is difficulty in defining dose-volume parameters to predict late renal toxicity after partial kidney irradiation. Less than 10% of the general population is estimated to have asymmetrical kidney function; however, there are no studies that examine this in patients with pancreatic cancer. The primary purpose of this study was to determine the prevalence of asymmetrical kidney function in patients with pancreatic cancer. A secondary aim was to determine if asymmetrical kidney function was associated with abnormal laboratory values or kidney size on computed tomography scans. Finally, we aimed to develop recommendations for when a functional renal scan in patients with pancreatic cancer should be ordered. METHODS AND MATERIALS: We performed a retrospective review of patients with resectable, borderline resectable, and locally advanced pancreatic cancer who received abdominal radiation therapy and had preradiation functional renal scans between 2009 and 2015. Asymmetrical kidney function was defined as a difference between the 2 kidneys that was ≥60%/40% on a functional renal scan. Serum studies (blood urea nitrogen [BUN], creatinine [Cr], and glomerular filtration rate [GFR]) and abdominal computed tomography scans were routinely obtained before simulation. RESULTS: Of the 204 patients examined, 23 (11.2%) had asymmetrical kidney function that was identified on preradiation functional renal scans. Elevated Cr or BUN, a GFR <60, or a medical history that suggested abnormal renal function were not significantly associated with asymmetrical kidney function. Only 6 of 23 patients (26%) with asymmetrical kidney function had a notable difference in kidney size. CONCLUSIONS: In our series, approximately 11% of patients with pancreatic cancer have asymmetrical kidney function that was not identified by kidney size, serum BUN, Cr, GFR, or a significant medical history. These data suggest that in cases in which renal radiation doses exceed a V18 of 20% to 30% or there is concern about baseline renal function, a functional renal scan should be considered.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Blitzer GC, Hall WA, Tsai S, et al. Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? Pract Radiat Oncol. 2017. PMID: 28886941. doi:10.1016/j.prro.2017.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。